{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:19:14Z","timestamp":1792667954071,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA083859"],"award-info":[{"award-number":["CA083859"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA06927"],"award-info":[{"award-number":["CA06927"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Health Research Formula Fund (CURE)"},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Daiichi Sankyo Co"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004897","name":"Pennsylvania Department of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004897","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002491","name":"Bristol Meyers Squibb","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Daiichi Sankyo Co"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.jaci.2013.07.006","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T02:01:50Z","timestamp":1375149710000},"page":"536-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":369,"title":["Natural killer cell biology: An update and future directions"],"prefix":"10.1016","volume":"132","author":[{"given":"Kerry S.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2013.07.006_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1182\/blood-2009-08-238469","article-title":"Regulation of human NK-cell cytokine and chemokine production by target cell recognition","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nature10624","article-title":"Natural killer cells act as rheostats modulating antiviral T cells","volume":"481","author":"Waggoner","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.006_bib4","article-title":"Crosstalk between neutrophils and dendritic cells: a context-dependent process","author":"Schuster","year":"2012","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2013.07.006_bib5","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000323923","article-title":"The bidirectional crosstalk between human dendritic cells and natural killer cells","volume":"3","author":"Wehner","year":"2011","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jaci.2013.07.006_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells\u2014a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nri3349","article-title":"Innate lymphoid cells\u2014how did we miss them?","volume":"13","author":"Walker","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib9","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2002-09-2876","article-title":"CD56bright natural killer cells are present in human lymph nodes and are activated by T cell derived IL-2: a potential new link between adaptive and innate immunity","volume":"101","author":"Fehniger","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib10","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-gamma for TH1 priming","volume":"5","author":"Martin-Fontecha","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib11","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1084\/jem.20100282","article-title":"Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking","volume":"207","author":"Fang","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.1012356108","article-title":"Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK cells as rapid producers of abundant IFN-gamma on activation","volume":"108","author":"De Maria","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.006_bib13","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0804224","article-title":"Killer Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals","volume":"182","author":"Korbel","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/cmi.2010.38","article-title":"Natural killer cell-triggered vascular transformation: maternal care before birth?","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib15","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/ACI.0b013e3280106b65","article-title":"Human natural killer cell deficiencies","volume":"6","author":"Orange","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib16","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u201cmissing self\u201d: MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"10.1016\/j.jaci.2013.07.006_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.coi.2010.11.005","article-title":"Viral evasion of T cell immunity: ancient mechanisms offering new applications","volume":"23","author":"Horst","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijc.21312","article-title":"Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation","volume":"118","author":"Seliger","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaci.2013.07.006_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fimmu.2012.00335","article-title":"Human NK cell lytic granules and regulation of their exocytosis","volume":"3","author":"Krzewski","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib20","first-page":"23","article-title":"Signal transduction in natural killer cells","volume":"298","author":"MacFarlane","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib21","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.4049\/jimmunol.1000855","article-title":"Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-Like RNA in human NK Cells","volume":"185","author":"Cichocki","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.gene.6364381","article-title":"Identification of bidirectional promoters in the human KIR genes","volume":"8","author":"Davies","year":"2007","journal-title":"Genes Immun"},{"key":"10.1016\/j.jaci.2013.07.006_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2004.06.005","article-title":"Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation","volume":"21","author":"Saleh","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.07.006_bib24","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-065X.2001.1810106.x","article-title":"The ever-expanding Ly49 gene family: repertoire and signaling","volume":"181","author":"Anderson","year":"2001","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2013.07.006_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.07.006_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib31","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1182\/blood-2012-05-429977","article-title":"Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins","volume":"120","author":"Brown","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib32","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.4049\/jimmunol.1000761","article-title":"Tethering of intercellular adhesion molecule on target cells is required for LFA-1\u2013dependent NK cell adhesion and granule polarization","volume":"185","author":"Gross","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood-2009-12-261487","article-title":"Elucidation of the integrin LFA-1\u2013mediated signaling pathway of actin polarization in natural killer cells","volume":"116","author":"Mace","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib34","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1002\/1521-4141(200111)31:11<3370::AID-IMMU3370>3.0.CO;2-2","article-title":"MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model","volume":"31","author":"Hanke","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood-2010-03-273656","article-title":"Analyses of HLA-C\u2013specific KIR repertoires in donors with group A\u00a0and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition","volume":"117","author":"Sch\u00f6nberg","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.07.006_bib37","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood-2008-05-156836","article-title":"The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells","volume":"113","author":"Brodin","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood-2006-07-036228","article-title":"A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature","volume":"110","author":"Cooley","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib39","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1073\/pnas.0712229105","article-title":"HLA alleles determine differences in human natural killer cell responsiveness and potency","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.006_bib40","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nri1863","article-title":"Self-tolerance of natural killer cells","volume":"6","author":"Raulet","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib41","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2004-08-3156","article-title":"A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules","volume":"105","author":"Fernandez","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","article-title":"Licensing of natural killer cells by host major histocompatibility complex class I molecules","volume":"436","author":"Kim","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.006_bib43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.1997.tb00938.x","article-title":"Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors","volume":"155","author":"Raulet","year":"1997","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2013.07.006_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(00)80393-3","article-title":"Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors","volume":"7","author":"Valiante","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.07.006_bib45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0198-8859(98)00097-4","article-title":"Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I)","volume":"60","author":"Furukawa","year":"1999","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1853205","article-title":"MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity","volume":"253","author":"Liao","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.07.006_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.it.2009.01.006","article-title":"NK cell education: not an on-off switch but a tunable rheostat","volume":"30","author":"Brodin","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib48","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.4049\/jimmunol.0803900","article-title":"NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model","volume":"182","author":"Joncker","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib49","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.immuni.2008.12.019","article-title":"A Role for cis interaction between the inhibitory Ly49A receptor and MHC class I for natural killer cell education","volume":"30","author":"Chalifour","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2013.07.006_bib50","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ni.1849","article-title":"'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection","volume":"11","author":"Orr","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib51","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20021836","article-title":"Interleukin (IL)-15R\u03b1-deficient natural killer cells survive in normal but not IL-15R\u03b1-deficient mice","volume":"197","author":"Koka","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib52","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4049\/jimmunol.172.2.864","article-title":"Turnover and proliferation of NK cells in steady state and lymphopenic conditions","volume":"172","author":"Jamieson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib53","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20021847","article-title":"In\u00a0vivo survival and homeostatic proliferation of natural killer cells","volume":"197","author":"Prlic","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib54","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.20100479","article-title":"Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection","volume":"208","author":"Sun","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nature07665","article-title":"Adaptive immune features of natural killer cells","volume":"457","author":"Sun","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.006_bib56","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.176.3.1517","article-title":"CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity","volume":"176","author":"Hayakawa","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1084\/jem.20111760","article-title":"Proinflammatory cytokine signaling required for the generation of natural killer cell memory","volume":"209","author":"Sun","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib58","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib59","doi-asserted-by":"crossref","first-page":"14725","DOI":"10.1073\/pnas.1110900108","article-title":"Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection","volume":"108","author":"Lopez-Verges","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.006_bib60","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"Beziat","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib61","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1084\/jem.20100762","article-title":"Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus","volume":"208","author":"Bj\u00f6rkstr\u00f6m","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib62","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.006_bib63","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1084\/jem.20120944","article-title":"Sustained effector function of IL-12\/15\/18-preactivated NK cells against established tumors","volume":"209","author":"Ni","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib64","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1182\/blood-2012-04-419283","article-title":"Cytokine activation induces human memory-like NK cells","volume":"120","author":"Romee","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/ni1332","article-title":"T cell- and B cell-independent adaptive immunity mediated by natural killer cells","volume":"7","author":"O'Leary","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib66","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ni.1953","article-title":"Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses","volume":"11","author":"Paust","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib67","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fimmu.2013.00076","article-title":"Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies","volume":"4","author":"Seidel","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib68","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2010-08-301945","article-title":"CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies","volume":"117","author":"Kohrt","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib69","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti\u2013PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib70","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.4049\/jimmunol.180.9.6392","article-title":"Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy","volume":"180","author":"Binyamin","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib71","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0901653106","article-title":"Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in\u00a0vivo","volume":"106","author":"Sola","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2013.07.006_bib72","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2009-02-206532","article-title":"Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells","volume":"114","author":"Romagne","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib73","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1182\/blood-2012-06-438028","article-title":"A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed\/refractory multiple myeloma","volume":"120","author":"Benson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib74","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2012-06-437558","article-title":"A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission","volume":"120","author":"Vey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib75","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1182\/blood-2011-06-360255","article-title":"IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect","volume":"118","author":"Benson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib76","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.07.006_bib77","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1084\/jem.20041214","article-title":"Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success","volume":"200","author":"Hiby","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib78","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4049\/jimmunol.1002906","article-title":"Analysis of binding of KIR3DS1*014 to HLA suggests distinct evolutionary history of KIR3DS1","volume":"187","author":"O'Connor","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib79","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nature10517","article-title":"Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B","volume":"479","author":"Vivian","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2013.07.006_bib80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2013.07.006_bib81","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ng2035","article-title":"Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1","volume":"39","author":"Martin","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2013.07.006_bib82","doi-asserted-by":"crossref","first-page":"e1001208","DOI":"10.1371\/journal.pbio.1001208","article-title":"Copy number variation of KIR genes influences HIV-1 control","volume":"9","author":"Pelak","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jaci.2013.07.006_bib83","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1471-4906(02)02284-6","article-title":"Alessandro, Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation","volume":"23","author":"Velardi","year":"2002","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib84","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaci.2013.07.006_bib85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib86","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2007-01-065383","article-title":"Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT","volume":"109","author":"Miller","year":"2007","journal-title":"Blood"},{"issue":"suppl\u00a01","key":"10.1016\/j.jaci.2013.07.006_bib87","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-0039.2006.759_5.x","article-title":"Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component","volume":"69","author":"Hsu","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaci.2013.07.006_bib88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humimm.2007.01.019","article-title":"Donor-recipient combinations of group A\u00a0and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation","volume":"68","author":"McQueen","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib89","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib90","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbmt.2010.03.004","article-title":"Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies","volume":"16","author":"Stringaris","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jaci.2013.07.006_bib91","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib92","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2010-02-269381","article-title":"NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation","volume":"117","author":"Haas","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib93","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in\u00a0vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib94","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaci.2013.07.006_bib95","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood-2011-01-329508","article-title":"Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients","volume":"118","author":"Curti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib96","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1537-2995.2012.03724.x","article-title":"Natural killer cells: a review of manufacturing and clinical utility","volume":"53","author":"Koepsell","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2013.07.006_bib97","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1537-2995.2012.03764.x","article-title":"Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions","volume":"53","author":"Klingemann","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2013.07.006_bib98","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib99","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa1103849","article-title":"Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia","volume":"365","author":"Porter","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2013.07.006_bib100","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1182\/blood-2011-04-348540","article-title":"Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias","volume":"118","author":"Brentjens","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib101","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1158\/1078-0432.CCR-08-2810","article-title":"2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cells","volume":"15","author":"Altvater","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2013.07.006_bib102","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2004-12-4797","article-title":"Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells","volume":"106","author":"Imai","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib103","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/cgt.2009.61","article-title":"Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method","volume":"17","author":"Li","year":"2010","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jaci.2013.07.006_bib104","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood.V100.4.1265.h81602001265_1265_1273","article-title":"Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction","volume":"100","author":"Uherek","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00262-007-0383-3","article-title":"Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells","volume":"57","author":"Muller","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2013.07.006_bib106","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/14653240802301872","article-title":"Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial","volume":"10","author":"Arai","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jaci.2013.07.006_bib107","first-page":"513702","article-title":"Molecular action of lenalidomide in lymphocytes and hematologic malignancies","volume":"2012","author":"McDaniel","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.jaci.2013.07.006_bib108","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00262-008-0512-7","article-title":"Immunomodulatory drugs Revlimid (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation","volume":"57","author":"Zhu","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2013.07.006_bib109","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05286.x","article-title":"Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application","volume":"128","author":"Hayashi","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2013.07.006_bib110","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1182\/blood-2010-04-278432","article-title":"The\u00a0immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy","volume":"117","author":"Hsu","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib111","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.jaci.2013.07.006_bib112","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1158\/1078-0432.CCR-07-4744","article-title":"Direct and natural killer cell-mediated antitumor effects of low-dose bortezomib in hepatocellular carcinoma","volume":"14","author":"Armeanu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2013.07.006_bib113","first-page":"388","article-title":"Novel immune modulators used in hematology: impact on NK cells","volume":"3","author":"Krieg","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2013.07.006_bib114","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1182\/blood-2008-11-190421","article-title":"Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells","volume":"113","author":"Lundqvist","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2013.07.006_bib115","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7150\/jca.2.383","article-title":"Bortezomib treatment to potentiate the anti-tumor immunity of ex-vivo expanded adoptively infused autologous natural killer cells","volume":"2","author":"Lundqvist","year":"2011","journal-title":"J Cancer"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913010658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674913010658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:40:59Z","timestamp":1758789659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674913010658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":115,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0091674913010658"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.006","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell biology: An update and future directions","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2013.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}